News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740,688 Results
Type
Article (42467)
Company Profile (309)
Press Release (697892)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (207582)
Career Advice (2070)
Deals (35896)
Drug Delivery (131)
Drug Development (82378)
Employer Resources (175)
FDA (16550)
Job Trends (15160)
News (350900)
Policy (33045)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2622)
Accelerated approval (45)
Adcomms (26)
Allergies (174)
Alliances (50471)
ALS (211)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (441)
Approvals (16924)
Artificial intelligence (662)
Autoimmune disease (281)
Automation (55)
Bankruptcy (365)
Best Places to Work (11706)
BIOSECURE Act (21)
Biosimilars (220)
Biotechnology (210)
Bladder cancer (186)
Brain cancer (70)
Breast cancer (746)
Cancer (5793)
Cardiovascular disease (465)
Career advice (1759)
Career pathing (41)
CAR-T (329)
CDC (56)
Celiac Disease (3)
Cell therapy (896)
Cervical cancer (46)
Clinical research (71423)
Collaboration (2069)
Company closure (5)
Compensation (1391)
Complete response letters (78)
COVID-19 (2768)
CRISPR (111)
C-suite (1126)
Cystic fibrosis (150)
Data (7795)
Decentralized trials (3)
Denatured (27)
Depression (163)
Dermatology (83)
Diabetes (586)
Diagnostics (6953)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (319)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (281)
Earnings (92380)
Editorial (68)
Employer branding (21)
Employer resources (154)
Events (122342)
Executive appointments (1094)
FDA (20256)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1731)
Gene editing (237)
Generative AI (59)
Gene therapy (726)
GLP-1 (1054)
Government (4754)
Grass and pollen (6)
Guidances (408)
Healthcare (19083)
HIV (80)
Huntington's disease (57)
IgA nephropathy (96)
Immunology and inflammation (285)
Immuno-oncology (93)
Indications (188)
Infectious disease (3106)
Inflammatory bowel disease (218)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (293)
Interviews (323)
IPO (16782)
IRA (50)
Job creations (3762)
Job search strategy (1463)
JPM (58)
Kidney cancer (19)
Labor market (98)
Layoffs (564)
Leadership (39)
Legal (8028)
Liver cancer (99)
Longevity (34)
Lung cancer (759)
Lymphoma (428)
Machine learning (61)
Management (59)
Manufacturing (1039)
MASH (183)
Medical device (13937)
Medtech (14048)
Mergers & acquisitions (20357)
Metabolic disorders (1491)
mRNA (201)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (412)
Neuropsychiatric disorders (105)
Neuroscience (3300)
Neurotech (1)
NextGen: Class of 2026 (6593)
Non-profit (4560)
Now hiring (77)
Obesity (698)
Opinion (297)
Ovarian cancer (217)
Pain (250)
Pancreatic cancer (300)
Parkinson's disease (360)
Partnered (33)
Patents (595)
Patient recruitment (667)
Peanut (63)
People (60627)
Pharmaceutical (63)
Pharmacy benefit managers (32)
Phase 1 (22349)
Phase 2 (31512)
Phase 3 (23295)
Pipeline (8385)
Policy (315)
Postmarket research (2577)
Preclinical (9536)
Press Release (71)
Prostate cancer (294)
Psychedelics (54)
Radiopharmaceuticals (321)
Rare diseases (1068)
Real estate (6133)
Recruiting (72)
Regulatory (25568)
Reports (57)
Research institute (2447)
Resumes & cover letters (358)
Rett syndrome (36)
RNA editing (21)
RSV (88)
Schizophrenia (177)
Series A (295)
Series B (217)
Service/supplier (11)
Sickle cell disease (115)
Special edition (24)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3747)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (89)
The Weekly (65)
Vaccines (1092)
Venture capital (110)
Weight loss (449)
Women's health (123)
Worklife (20)
Date
Today (135)
Last 7 days (926)
Last 30 days (3239)
Last 365 days (30609)
2026 (11826)
2025 (30611)
2024 (35629)
2023 (40427)
2022 (51638)
2021 (56108)
2020 (54478)
2019 (46908)
2018 (35344)
2017 (32524)
2016 (32052)
2015 (38031)
2014 (31812)
2013 (26847)
2012 (29162)
2011 (29834)
2010 (27936)
Location
Africa (771)
Alabama (91)
Alaska (7)
Arizona (349)
Arkansas (15)
Asia (40618)
Australia (6789)
California (13214)
Canada (3725)
China (1343)
Colorado (563)
Connecticut (575)
Delaware (400)
Europe (88583)
Florida (1959)
Georgia (424)
Hawaii (3)
Idaho (62)
Illinois (1070)
India (88)
Indiana (597)
Iowa (24)
Japan (530)
Kansas (134)
Kentucky (51)
Louisiana (40)
Maine (75)
Maryland (1578)
Massachusetts (9462)
Michigan (360)
Minnesota (709)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (140)
New Hampshire (85)
New Jersey (3472)
New Mexico (30)
New York (3453)
North Carolina (1694)
North Dakota (10)
Northern California (6617)
Ohio (392)
Oklahoma (23)
Oregon (41)
Pennsylvania (2652)
Puerto Rico (29)
Rhode Island (50)
South America (1153)
South Carolina (85)
South Dakota (2)
Southern California (5200)
Tennessee (209)
Texas (2088)
United States (46649)
Utah (398)
Vermont (1)
Virginia (317)
Washington D.C. (80)
Washington State (1070)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
740,688 Results for "teselagen biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
TeselaGen Announces Spin-Off, Built Biotechnologies, Aims to Advance DNA Manufacturing
TeselaGen Biotechnology, Inc., a leader in the field of biological design and process automation, announces its DNA manufacturing spin-off, Built Biotechnologies, Inc. (“Built”).
December 6, 2023
·
2 min read
Business
TeselaGen Biotechnology Renews Partnership with Joint BioEnergy Institute to Enhance Production of Carbon Neutral Bioproducts
TeselaGen and the Joint BioEnergy Institute (JBEI) have signed a new 5-year contract to add expanded workflow capabilities, extending their relationship through 2027.
September 26, 2023
·
2 min read
TeselaGen Receives Two New Patents for Using Artificial Intelligence to Accelerate Biotech Product Development
TeselaGen Biotechnology Inc., the software company providing an all-in-one platform for seamless, scalable biotech R&D, announces the acquisition of two cutting-edge patents that advance AI-driven optimization of biological phenotypes.
October 17, 2023
·
2 min read
Biotech Bay
TeselaGen Support Helps Early-Stage BioTech Startups Scale Faster and More Efficiently with Its Starter Edition
TeselaGen Biotechnology Inc. announces the launch of its Starter Edition, a version of TeselaGen’s software supporting innovative early-stage biotech companies that are ready to scale.
March 21, 2023
·
3 min read
Press Releases
TeselaGen Launches Its Next-Gen Electronic Lab Notebook and Enhanced Interface to Accelerate Biotech Research
December 6, 2024
·
2 min read
Business
TeselaGen and NinthBio Partner to Empower Users with Advanced DNA Variant Library Construction; Announcing Homology Path Design Algorithm Integration to Speed BioTech Development
TeselaGen Biotechnology Inc., pioneer in AI-enabled Operating Systems for Biotechnology R&D and Manufacturing announces a strategic partnership with NinthBio LLC, the visionary Smart DNA Assembly Technology company.
May 23, 2023
·
4 min read
Press Releases
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development - February 10, 2026
February 11, 2026
·
3 min read
Press Releases
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
May 6, 2026
·
3 min read
Press Releases
Puma Biotechnology Reports First Quarter 2026 Financial Results
May 8, 2026
·
15 min read
Press Releases
MilliporeSigma Builds On its Legacy As a Biotechnology Leader in Temecula
May 5, 2026
·
1 min read
1 of 74,069
Next
